Differentiation of desquamative interstitial pneumonia (DIP) from pulmonary adenocarcinoma by immunocytochemistry

19Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Aim: After a misdiagnosis of pulmonary adenocarcinoma as desquamative interstitial pneumonia (DIP), we investigated whether immunohistochemical markers could differentiate these conditions. Methods and results: Three cases of DIP and one pulmonary adenocarcinoma masquerading as DIP were studied by light and electron microscopy. All cases were mucin-negative. The cases of DIP were CD68 positive but cytokeratin-negative. The adenocarcinoma was cytokeratin-positive (AE1/3 and CAM5.2), as well as showing some CD68- positive cells. Markers for carcinoma (CEA, Ber-EP4, and Leu M1) were negative in all cases. Ultrastructurally the adenocarcinoma appeared to be derived from Type II pneumocytes. Conclusion: Before a diagnosis of DIP is made, cytokeratin markers should be used.

Cite

CITATION STYLE

APA

Mutton, A. E., Hasleton, P. S., Curry, A., Bishop, P. W., Egan, J., Carroll, K. B., & Hanley, S. (1998). Differentiation of desquamative interstitial pneumonia (DIP) from pulmonary adenocarcinoma by immunocytochemistry. Histopathology, 33(2), 129–135. https://doi.org/10.1046/j.1365-2559.1998.00463.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free